Clinical Trials

Clinical Trials are the primary way that researchers find out if a new treatment, like a new drug or diet or medical device (for example, a pacemaker) is safe and effective in people. Qizen Therapeutics has been conducting clinical trials in various disease indications.

Our Work

We are supporting innovation in science through research

We carry out scientific studies designed to evaluate the effectiveness and safety of a new drug by monitoring their effects. Qizen Therapeutics clinical trials in various disease indications have involved trials of drugs which are usually described based on their phase. We carryout out Phase I, II, and III trials to help the PDA determine if a drug can be approved for use.

* A Phase I trial tests an experimental treatment on a small group of often healthy people (20 to 80) to judge its safety and side effects and to find the correct drug dosage.

* A Phase II trial uses more people (100 to 300). While the emphasis in Phase I is on safety, the emphasis in Phase II is on effectiveness. This phase aims to obtain preliminary data on whether the drug works in people who have a certain disease or condition. These trials also continue to study safety, including short-term side effects. This phase can last several years.

* A Phase III trial gathers more information about safety and effectiveness, studying different populations and different dosages, using the drug in combination with other drugs. The number of subjects usually ranges from several hundred to about 3,000 people. If the FDA agrees that the trial results are positive, it will approve the experimental drug or device.

* A Phase IV trial for drugs or devices takes place after the FDA approves their use. A device or drug’s effectiveness and safety are monitored in large, diverse populations. Sometimes, the side effects of a drug may not become clear until more people have taken it over a longer period of time.

Clinical Development

We have been working to develop cure to diseases.

Scientific Networking

We have worked in connecting discoveries across experts.


We are giving better life to the living with the living.

Value Chain

Value creation between early discovery to clinical proof-of-concept.

          Code               Condition/Disease          Phase              Status

Psoriasis II Ongoing
Anti-Microbial, Qz313 Healthy volunteers I Ongoing
Anti-Bacteria, Qz113 Healthy volunteers II Ongoing
Telacebec, Qz156 Pulmonary Tuberculosis II Ongoing
Qz315 Atopic Dermatitis I Ongoing
Qz109 Atopic Dermatitis I Ongoing

For more information about Clinical Trials